Keywords: bristol-myers, squibb, focus, pharma, selling, off, clairol

Bristol-Myers Squibb to focus more on pharma, selling off Clairol and Zimmer

Article | 29 September 2000

Print This

Bristol-Myers Squibb has held its first formal analysts' presentationfor three years and announced "a strategy of growth" that involves a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in